Press Releases

BOTHELL, Wash., Nov. 12, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfoli

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that the

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the third quarter ended September 30, 2019 and provided an update on its recent corporate activities and outlook."We have transitioned our strategy to focus solely on our high-growth, high-margin ENHANZE® drug delivery t

SAN FRANCISCO, Nov. 12, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the third quarter ended September 30, 2019 and provided updates on its programs. For the third quarter 2019, KindredBio reported

CLEVELAND, Nov. 12, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the third quarter ended September 30, 2019.

SALT LAKE CITY, Nov. 12, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter and nine months ended September 30, 2019, and provided a corporate update.

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- On November 14th, Yankee Stadium will transform from the world's most iconic ballpark into a beacon of hope for young people overcoming homelessness.That's when Yankees General Manager Brian Cashman will join over 200 other leaders to sleep at the Stadiu

ALEXANDRIA, Va., Nov. 12, 2019 /PRNewswire/ -- While the holidays are a very social time of year, they can also be a very lonely time for many people. The Better Sleep Council&nb

SAN CARLOS, Calif. and WASHINGTON, Nov. 12, 2019 /PRNewswire/ -- GO2 Foundation for Lung Cancer (a merger of the Bonnie J. Addario Lung

RANCHO CORDOVA, Calif., Nov. 12, 2019 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), formerly known as Cesca Therapeutics Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced it will delay its third quarter ended September 30, 2019 earnings release a